Novo increases digital effort: "We want to be leading in the field"

Novo Nordisk expands the workforce to develop of digital products such as insulin pens registering doses in an app. The goal is to beat the competition from Eli Lilly and Sanofi.

Photo: Novo Nordisk / PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles